Skip to main content
OpenTrials
Completed

NCT Number: NCT01683487

Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.

I. To investigate time measurement from emergency room admission to first antibiotic administration.

II. To evaluate risk factors for prolonged time to first antibiotic administration.

III. To correlate time measurement with Charlson comorbidity index and multimorbidity patterns.

IV. To investigate the impact of a delayed time to first antibiotic administration on the outcome

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Zurich, Division of Internal Medicine

Zurich, Canton of Zurich, 8091, Switzerland

About this study

In this retrospective cohort study, we plan to include all patients presenting with a community-acquired pneumococcal pneumonia at the University Hospital of Zurich between January 1, 2006 and June 30, 2012 (6½ years). The patients will be identified either with one or more blood culture pairs positive for S. pneumoniae or with a positive pneumococcal urine antigen assay in combination with the clinical diagnosis of CAP, which was based on the presence of select clinical features (e.g., cough, fever, sputum production, and pleuritic chest pain) and is supported by imaging of the lung, usually by chest radiography according to Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults [11].

CAP is not considered if the patient is discharged from a hospital less than 7 days before the current hospital admission, if the first blood culture or urinary antigen assay is obtained more than 1 week after hospital admission, or if the patient has no clinical diagnosis of CAP at the time of admission. Patients referred from or transferred to another hospital are excluded.

After identification of eligible patients upon microbiological results, medical records are reviewed using a standardized data collection questionnaire. Comorbidity is determined using the Charlson comorbidity index [10]. Additionally, all patients are classified according to the multimorbidity patterns proposed by Holden et al. [12]. These are:

  • arthritis, osteoporosis, other chronic pain, bladder problems, and irritable bowel;
  • asthma, chronic obstructive pulmonary disease, and allergies;
  • back/neck pain, migraine, other chronic pain, and arthritis;
  • high blood pressure, high cholesterol, obesity, diabetes, and fatigue;
  • cardiovascular disease, diabetes, fatigue, high blood pressure, high cholesterol, and arthritis; and
  • irritable bowel, ulcer, heartburn, and other chronic pain.

Time calculation is based upon the moment of emergency room (ER) admission.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with community-acquired pneumococcal pneumonia, which was confirmed by

  • detection of Streptococcus pneumoniae in blood cultures, tracheal secretion or sputum OR/AND
  • positive urinary pneumococcal antigen AND
  • presence of cough and presence of one of the following signs/symptoms: new focal chest signs; dyspnoea; tachypnoea; fever AND
  • radiologic signs of pneumonia

Exclusion criteria

- Pneumonia of other cause (e.g. non-pneumococcal pneumonia)

  • Hospital-acquired or ventilator-associated pneumonia
  • Patients referred from or transferred to another hospital

Treatment and study plan

observation

Procedure

Observational study only, no intervention.

Primary outcomes

  1. In-hospital mortaliy

    Time frame: From day of admission until discharge or dead

    Mortality during hospitalization because of pneumococcal pneumonia

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. Analysis of Risk Factors and Impact on the Outcome.

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
Sep 11, 2012
Registry last updated
May 28, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.